Endocrine and Bone Monitoring in Boys with Duchenne Muscular Dystrophy; Do we adhere to the standards of care?
J Neuromuscul Dis
.
2023;10(6):1143-1144.
doi: 10.3233/JND-230144.
Authors
A Henderson
1
,
G Harley
2
,
I Horrocks
3
,
S Joseph
3
,
J Dunne
3
,
K Pysden
1
,
T Mushtaq
4
,
S C Wong
2
,
A M Childs
1
Affiliations
1
Department of Paediatric Neurology, Leeds Children's Hospital, UK.
2
Department of Paediatric Endocrinology, Royal Hospital for Children Glasgow, UK.
3
Department of Paediatric Neurology, Royal Hospital for Children Glasgow, UK.
4
Department of Paediatric Endocrinology, Leeds Children's Hospital, UK.
PMID:
37927273
PMCID:
PMC10657663
DOI:
10.3233/JND-230144
No abstract available
MeSH terms
Bone and Bones
Humans
Male
Men
Muscular Dystrophy, Duchenne* / therapy
Reference Standards
Standard of Care
Grants and funding
CAF/DMD/14/01/CSO_/Chief Scientist Office/United Kingdom